Matthew Gall
Director of Finance/CFO chez ITEOS THERAPEUTICS, INC.
Fortune : 824 252 $ au 31/03/2024
Profil
Matthew Gall is currently the Chief Financial Officer at iTeos Therapeutics, Inc. Prior to this, he worked as the Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
He completed his undergraduate degree at Bowling Green State University and earned an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
0,17% | 07/03/2024 | 60 429 ( 0,17% ) | 824 252 $ | 31/03/2024 |
Postes actifs de Matthew Gall
| Sociétés | Poste | Début |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2020 |
Anciens postes connus de Matthew Gall
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Formation de Matthew Gall
| Bowling Green State University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
